Two Sigma Investments’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,700
Closed -$949K 4576
2021
Q4
$949K Buy
11,700
+6,900
+144% +$691K ﹤0.01% 2600
2021
Q3
$559K Buy
+4,800
New +$628K ﹤0.01% 3158
2021
Q1
Sell
-2,800
Closed -$485K 4332
2020
Q4
$485K Buy
+2,800
New +$453K ﹤0.01% 2544
2020
Q3
Sell
-3,200
Closed -$382K 3646
2020
Q2
$382K Buy
3,200
+400
+14% +$47.4K ﹤0.01% 2204
2020
Q1
$280K Sell
2,800
-100
-3% -$12K ﹤0.01% 2372
2019
Q4
$341K Sell
2,900
-2,100
-42% -$208K ﹤0.01% 3092
2019
Q3
$430K Buy
+5,000
New +$378K ﹤0.01% 2677
2018
Q4
Sell
-4,000
Closed -$228K 3630
2018
Q3
$228K Buy
+4,000
New +$250K ﹤0.01% 2933
2018
Q2
Sell
-10,400
Closed -$901K 3735
2018
Q1
$901K Buy
+10,400
New +$840K ﹤0.01% 2076

Other funds holding NVRO

Two Sigma Investments's NVRO Position: Q2 2025 in Review

Two Sigma Investments sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 330,902 shares — an estimated $1.93M sold.

Two Sigma Investments first reported a position in NVRO in Q2 2015 and held it in 26 quarters. The position peaked at $33.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Two Sigma Investments reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Investments sold 330,902 NEVRO CORP. shares in Q2 2025, an estimated $1.93M.
  • Two Sigma Investments first reported a position in NEVRO CORP. in Q2 2015 and held it in 26 quarters.
  • Two Sigma Investments's NEVRO CORP. position peaked at $33.5M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.